论文部分内容阅读
目的 :探讨在糖尿病早期肾损伤诊断中,采取尿糖微量白蛋白联合检测后,对疾病诊断的价值。方法 :选取2015年3月到2016年3月期间,在我院进行体检的健康个体作为对照组,共计60例。另外,选取同一时间在我院治疗的60例糖尿病患者作为观察组。两组均给予尿糖尿微量白蛋白联合检验。对比两组对象的尿糖、尿微量白蛋白水平。结果 :观察组的尿糖、尿微量白蛋白水平分别为(3.7±0.4)、(172.3±10.5)。对照组的尿糖、尿微量白蛋白水平分别为(1.2±0.3)、(16.0±2.2)。观察组与对照组相比,尿糖、尿微量白蛋白水平更高。差异显著,P<0.05,具有统计学意义。结论:在糖尿病早期肾损伤诊断中,采用尿糖尿微量白蛋白联合检验方法,能够作为有效地诊断依据。因此,值得在临床上大力推广。
OBJECTIVE: To investigate the diagnostic value of urine albumin microalbumin in the diagnosis of early diabetic kidney injury. Methods: From March 2015 to March 2016, 60 healthy subjects were selected as the control group in our hospital. In addition, select the same time in our hospital treated 60 cases of diabetic patients as the observation group. Both groups were given urinary albumin microalbuminuria test. Urine and urine microalbumin levels were compared between two groups. Results: Urine and urine microalbuminuria in the observation group were (3.7 ± 0.4) and (172.3 ± 10.5), respectively. Urine and urine microalbuminuria in the control group were (1.2 ± 0.3) and (16.0 ± 2.2), respectively. Compared with the control group, the urine glucose and urine microalbumin levels in the observation group were higher. Significant difference, P <0.05, with statistical significance. Conclusion: In the early diagnosis of diabetic nephropathy, urine urinary albumin microalbuminuria test method can be used as an effective basis for diagnosis. Therefore, it is worth to vigorously promote in clinic.